IBDEI0CC ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16473,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,16474,0)
 ;;=202.40^^107^959^41
 ;;^UTILITY(U,$J,358.3,16474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16474,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,16474,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,16474,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,16475,0)
 ;;=173.91^^107^959^6
 ;;^UTILITY(U,$J,358.3,16475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16475,1,4,0)
 ;;=4^173.91
 ;;^UTILITY(U,$J,358.3,16475,1,5,0)
 ;;=5^Basal Cell CA Skin,Site Unspec
 ;;^UTILITY(U,$J,358.3,16475,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,16476,0)
 ;;=160.9^^107^959^19
 ;;^UTILITY(U,$J,358.3,16476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16476,1,4,0)
 ;;=4^160.9
 ;;^UTILITY(U,$J,358.3,16476,1,5,0)
 ;;=5^Ca Accessory Sinuses
 ;;^UTILITY(U,$J,358.3,16476,2)
 ;;=^267127
 ;;^UTILITY(U,$J,358.3,16477,0)
 ;;=211.3^^107^959^40
 ;;^UTILITY(U,$J,358.3,16477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16477,1,4,0)
 ;;=4^211.3
 ;;^UTILITY(U,$J,358.3,16477,1,5,0)
 ;;=5^Colon Polyps (Current)
 ;;^UTILITY(U,$J,358.3,16477,2)
 ;;=^13295
 ;;^UTILITY(U,$J,358.3,16478,0)
 ;;=214.9^^107^959^44
 ;;^UTILITY(U,$J,358.3,16478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16478,1,4,0)
 ;;=4^214.9
 ;;^UTILITY(U,$J,358.3,16478,1,5,0)
 ;;=5^Lipoma NOS
 ;;^UTILITY(U,$J,358.3,16478,2)
 ;;=^71155
 ;;^UTILITY(U,$J,358.3,16479,0)
 ;;=185.^^107^959^49
 ;;^UTILITY(U,$J,358.3,16479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16479,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,16479,1,5,0)
 ;;=5^Mal Neo Prostate
 ;;^UTILITY(U,$J,358.3,16479,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,16480,0)
 ;;=173.90^^107^959^50
 ;;^UTILITY(U,$J,358.3,16480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16480,1,4,0)
 ;;=4^173.90
 ;;^UTILITY(U,$J,358.3,16480,1,5,0)
 ;;=5^Mal Neo Skin,Unspec/Site Unspec
 ;;^UTILITY(U,$J,358.3,16480,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,16481,0)
 ;;=173.92^^107^959^69
 ;;^UTILITY(U,$J,358.3,16481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16481,1,4,0)
 ;;=4^173.92
 ;;^UTILITY(U,$J,358.3,16481,1,5,0)
 ;;=5^Squam Cell CA Skin,Site Unspec
 ;;^UTILITY(U,$J,358.3,16481,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,16482,0)
 ;;=218.9^^107^959^71
 ;;^UTILITY(U,$J,358.3,16482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16482,1,4,0)
 ;;=4^218.9
 ;;^UTILITY(U,$J,358.3,16482,1,5,0)
 ;;=5^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,16482,2)
 ;;=^68944
 ;;^UTILITY(U,$J,358.3,16483,0)
 ;;=112.1^^107^960^42
 ;;^UTILITY(U,$J,358.3,16483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16483,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,16483,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,16483,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,16484,0)
 ;;=110.1^^107^960^5
 ;;^UTILITY(U,$J,358.3,16484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16484,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,16484,1,5,0)
 ;;=5^Dermatophytosis Nail
 ;;^UTILITY(U,$J,358.3,16484,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,16485,0)
 ;;=098.0^^107^960^37
 ;;^UTILITY(U,$J,358.3,16485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16485,1,4,0)
 ;;=4^098.0
 ;;^UTILITY(U,$J,358.3,16485,1,5,0)
 ;;=5^Urethritis,Gonococcal
 ;;^UTILITY(U,$J,358.3,16485,2)
 ;;=^52567
 ;;^UTILITY(U,$J,358.3,16486,0)
 ;;=054.13^^107^960^19
 ;;^UTILITY(U,$J,358.3,16486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16486,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,16486,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,16486,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,16487,0)
 ;;=054.11^^107^960^21
 ;;^UTILITY(U,$J,358.3,16487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16487,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,16487,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,16487,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,16488,0)
 ;;=053.9^^107^960^18
 ;;^UTILITY(U,$J,358.3,16488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16488,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,16488,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,16488,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,16489,0)
 ;;=088.81^^107^960^22
 ;;^UTILITY(U,$J,358.3,16489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16489,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,16489,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,16489,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,16490,0)
 ;;=031.0^^107^960^23
 ;;^UTILITY(U,$J,358.3,16490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16490,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,16490,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,16490,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,16491,0)
 ;;=136.3^^107^960^24
 ;;^UTILITY(U,$J,358.3,16491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16491,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,16491,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,16491,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,16492,0)
 ;;=091.0^^107^960^31
 ;;^UTILITY(U,$J,358.3,16492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16492,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,16492,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,16492,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,16493,0)
 ;;=094.9^^107^960^30
 ;;^UTILITY(U,$J,358.3,16493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16493,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,16493,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,16493,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,16494,0)
 ;;=097.9^^107^960^28
 ;;^UTILITY(U,$J,358.3,16494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16494,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,16494,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,16494,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,16495,0)
 ;;=011.90^^107^960^35
 ;;^UTILITY(U,$J,358.3,16495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16495,1,4,0)
 ;;=4^011.90
 ;;^UTILITY(U,$J,358.3,16495,1,5,0)
 ;;=5^Tuberculosis
 ;;^UTILITY(U,$J,358.3,16495,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,16496,0)
 ;;=131.02^^107^960^38
 ;;^UTILITY(U,$J,358.3,16496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16496,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,16496,1,5,0)
 ;;=5^Urethritis,Trichomonal
 ;;^UTILITY(U,$J,358.3,16496,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,16497,0)
 ;;=597.80^^107^960^39
 ;;^UTILITY(U,$J,358.3,16497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16497,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,16497,1,5,0)
 ;;=5^Urethritis,Unsp
 ;;^UTILITY(U,$J,358.3,16497,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,16498,0)
 ;;=079.99^^107^960^41
 ;;^UTILITY(U,$J,358.3,16498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16498,1,4,0)
 ;;=4^079.99
 ;;^UTILITY(U,$J,358.3,16498,1,5,0)
 ;;=5^Viral Syndrome
 ;;^UTILITY(U,$J,358.3,16498,2)
 ;;=^295798
 ;;^UTILITY(U,$J,358.3,16499,0)
 ;;=131.01^^107^960^40
 ;;^UTILITY(U,$J,358.3,16499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16499,1,4,0)
 ;;=4^131.01
 ;;^UTILITY(U,$J,358.3,16499,1,5,0)
 ;;=5^Vaginitis, Trichomonas
 ;;^UTILITY(U,$J,358.3,16499,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,16500,0)
 ;;=070.1^^107^960^12
 ;;^UTILITY(U,$J,358.3,16500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16500,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,16500,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,16500,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,16501,0)
 ;;=070.30^^107^960^13
 ;;^UTILITY(U,$J,358.3,16501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16501,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,16501,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,16501,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,16502,0)
 ;;=070.32^^107^960^14
 ;;^UTILITY(U,$J,358.3,16502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16502,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,16502,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,16502,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,16503,0)
 ;;=070.51^^107^960^15
 ;;^UTILITY(U,$J,358.3,16503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16503,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,16503,1,5,0)
 ;;=5^Hepatitis C Acute
 ;;^UTILITY(U,$J,358.3,16503,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,16504,0)
 ;;=042.^^107^960^11
 ;;^UTILITY(U,$J,358.3,16504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16504,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,16504,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,16504,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,16505,0)
 ;;=054.12^^107^960^20
 ;;^UTILITY(U,$J,358.3,16505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16505,1,4,0)
 ;;=4^054.12
 ;;^UTILITY(U,$J,358.3,16505,1,5,0)
 ;;=5^Herpetic Infect of Vulva
 ;;^UTILITY(U,$J,358.3,16505,2)
 ;;=^266559
 ;;^UTILITY(U,$J,358.3,16506,0)
 ;;=795.51^^107^960^36
 ;;^UTILITY(U,$J,358.3,16506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16506,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,16506,1,5,0)
 ;;=5^Tuberculosis Skin Test Pos W/O Active TB
 ;;^UTILITY(U,$J,358.3,16506,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,16507,0)
 ;;=097.1^^107^960^29
 ;;^UTILITY(U,$J,358.3,16507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16507,1,4,0)
 ;;=4^097.1
 ;;^UTILITY(U,$J,358.3,16507,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,16507,2)
 ;;=^116843
 ;;^UTILITY(U,$J,358.3,16508,0)
 ;;=054.9^^107^960^17
 ;;^UTILITY(U,$J,358.3,16508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16508,1,4,0)
 ;;=4^054.9
 ;;^UTILITY(U,$J,358.3,16508,1,5,0)
 ;;=5^Herpes Simplex,Mouth/Lip
 ;;^UTILITY(U,$J,358.3,16508,2)
 ;;=^56902
 ;;^UTILITY(U,$J,358.3,16509,0)
 ;;=112.84^^107^960^1
 ;;^UTILITY(U,$J,358.3,16509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16509,1,4,0)
 ;;=4^112.84
 ;;^UTILITY(U,$J,358.3,16509,1,5,0)
 ;;=5^Candidiasis Esophagitis
 ;;^UTILITY(U,$J,358.3,16509,2)
 ;;=^259729
 ;;^UTILITY(U,$J,358.3,16510,0)
 ;;=112.0^^107^960^2
 ;;^UTILITY(U,$J,358.3,16510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16510,1,4,0)
 ;;=4^112.0
 ;;^UTILITY(U,$J,358.3,16510,1,5,0)
 ;;=5^Candidiasis,Oral
 ;;^UTILITY(U,$J,358.3,16510,2)
 ;;=^18599
 ;;^UTILITY(U,$J,358.3,16511,0)
 ;;=070.54^^107^960^16
